CN1183986A - Chinese medicine Pingguxiaociwan for curing Bi-syndrome - Google Patents
Chinese medicine Pingguxiaociwan for curing Bi-syndrome Download PDFInfo
- Publication number
- CN1183986A CN1183986A CN 97122390 CN97122390A CN1183986A CN 1183986 A CN1183986 A CN 1183986A CN 97122390 CN97122390 CN 97122390 CN 97122390 A CN97122390 A CN 97122390A CN 1183986 A CN1183986 A CN 1183986A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- chinese
- chinese patent
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 241000717739 Boswellia sacra Species 0.000 claims description 7
- 241000903946 Clematidis Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 239000004863 Frankincense Substances 0.000 claims description 7
- 241001057584 Myrrha Species 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 19
- 208000002193 Pain Diseases 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 210000003734 kidney Anatomy 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 238000010792 warming Methods 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 6
- 239000006187 pill Substances 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010005963 Bone formation increased Diseases 0.000 description 3
- 201000005569 Gout Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 208000012287 Prolapse Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine is compounded with 15 Chinese medicinal materials including Chinese angelica, Astragalus membranaceus, Radix Paeoniae Alba, solomonseal, Rhizoma ligustici Chuanxiong, etc. It has the functions of invigorating kidney, tonifying Qi, promoting blood circulation, stopping pain, warming the channels and dissipating cold and others, so that it has high cure effect and less toxic side effect in curing empediment (bi) syndrome.
Description
The invention belongs to the medicine of treatment arthromyodynia, be specifically related to a kind of Chinese patent medicine for the treatment of arthromyodynia.
The record of arthromyodynia in TCM Document, see the earliest " element is asked. the numbness opinion " and, " wet three gas of wind and cold are assorted extremely, close and be numbness ", " so-called numbness person, each in the wet gas of wind and cold also " with reinfection at that time.Therefore, the traditional Chinese medical science is thought arthromyodynia mainly due to positive QI-insufficiency, experiences due to wind, cold, wet, the hot heresy.
Modern medicine is observed in clinical, the scope that arthromyodynia comprises is very extensive, symptoms such as all arthralgias, enlargement distortion, joint joint stuffiness are all classified the arthromyodynia category as, therefore, in conjunction with modern medicine, it can comprise rheumatism atrophic arthritis, diseases such as the arthralgia that gout, hyperosteogeny cause, sciatica and hyperplastic spondylitis.Because human body is suffered from similar symptom is all arranged when stating disease, thus the sickness rate of arthromyodynia can't accurately estimate, only be example with the rheumatoid arthritis, China's prevalence is about 1 ‰ (" commonly encountered diseases tcm clinical practice therapeutic advances ", China Chinese medicine publishing house published 93 pages in 1991).
Doctor trained in Western medicine generally adopts salicylic acid preparation or hormonotherapy to above-mentioned treatment of diseases, but effect is undesirable and side effect is bigger, is the problem that contemporary medical science circle is paid close attention to so inquire into tcm therapy.
Purpose of the present invention aims to provide the Chinese patent medicine of a kind of good effect, treatment arthromyodynia that toxic and side effects is little.
For reaching above-mentioned purpose, solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of Chinese medicine to arthromyodynia, consulted in a large number document at all times, again through clinical research for many years, from motherland's medical treasure-house, filter out tonify Qi of the kidney, the Chinese herbal medicine of promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening, by traditional Chinese medical science prescription theory, be prepared into oral Chinese patent medicine.
Theory of Chinese medical science thinks, arthromyodynia owing to wind, cold, wet, heat is assorted is the exopathogenic factor of assertive evidence to causing a disease, still, " institute of heresy gathers, its gas must void ", in the human righteousness lost, exopathogen can be invaded.Therefore, it will be argued that, tonify Qi of the kidney, promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening, is the main rule of treatment primary disease, also is the basic foundation of prescription, meets the generation and the law of development of primary disease.
The raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are (b is Unit Weight part):
Radix Angelicae Sinensis 35-45b Radix Astragali 55-65b Radix Paeoniae Alba 30-40b Rhizoma Polygonati 25-35b
Rhizoma Chuanxiong 25-35b Flos Carthami 15-21b Olibanum 17-23b Myrrha 17-23b
Cortex Eucommiae 35-45b Herba Taxilli 20-30b Fructus Lycii 25-35b Radix Angelicae Pubescentis 25-35b
Radix Gentianae Macrophyllae 25-35b Radix Clematidis 25-35b Rhizoma Zingiberis Recens 25-35b
Above-mentioned Chinese medicine raw materials by weight proportion is made middle clothes Chinese patent medicine.
Pharmaceutical analysis:
Radix Angelicae Sinensis among the above-mentioned side, the Radix Astragali, Rhizoma Polygonati, Fructus Lycii, the Radix Paeoniae Alba for tonify Qi of the kidney, nourshing Yin and drynsessmoistening prescription product, but Radix Astragali human body immunity improving function wherein, Fructus Lycii contains several amino acids and the endocrine regulation effect is arranged (referring to " Chinese medicine modern study and clinical practice ", the Xueyuan Press, nineteen ninety-five publishes, 478 pages); Rhizoma Chuanxiong, Flos Carthami, Olibanum, Myrrha are medicine for promoting blood circulation and dispelling blood stasis, can improve to be equipped with blood microcirculation in the body, reach the pain relieving purpose by invigorating blood circulation; The Cortex Eucommiae, Herba Taxilli, Radix Gentianae Macrophyllae, Radix Clematidis dredge the meridian passage, the damp eliminating bone strengthening, wherein the Cortex Eucommiae contains eucommoil and multiple organic acid, the immunologic function that is significantly improved and anti-stress effect; Radix Angelicae Pubescentis has the effect of inducing sweat, and is the main separation medicine of treatment rheumatalgia; Rhizoma Zingiberis Recens has dispelling cold by warming the meridian, anti-inflammatory analgesic action.Full side's compatibility, scientific strong, treating both the principal and secondary aspects of a disease, can reach tonify Qi of the kidney, the effect of promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening.
Efficacy analysis:
The inventor once treated thousands of routine arthromyodynia patients with this medicine, all received satisfactory effect to improving its symptom, and the elite 300 complete example statistics of record material of selecting are as follows:
| Rheumatism, rheumatoid arthritis pain | Produce effects 53 | Progressive 67 | Invalid 4 | Subtotal 124 |
| Gout | ????9 | ????13 | ????2 | ????24 |
| The arthralgia that hyperosteogeny and intervertebral disk hernia cause | ????33 | ????40 | ????3 | ????76 |
| The numb limbs and tense tendons that a variety of causes causes, handicapped | ????26 | ????16 | ????0 | ????42 |
| Other | ????18 | ????14 | ????2 | ????34 |
| Amount to | ????139 ????(46.3％) | ????150 ????(50％) | ????11 ????(3.7％) | ????300 |
By above statistics as can be known, this medicine total effective rate is 96.3%, and except that gout, symptom such as the arthralgia that a variety of causes is caused, numb limbs and tense tendons, activities adverse all has satisfactory effect.
Model case:
Example one, Li Zhirong, man, 65 years old, area just outside a city gate town, Xia County, Shanxi Province retired worker.
Because of the working environment humidity, suffered from rheumatic arthritis before more than ten years, both legs pain, morning, deadlock was more serious when day cold, can not normal activity, the influence life.Once used the Western medicine pain relieving, DeGrain comes the court to go to a doctor February 18 nineteen ninety-five, looks into patient's moving difficulty, and right leg joint is swollen to rise, patient's poor appetite, and lustreless complexion, white and thin fur, thready and rapid pulse gives Chinese patent medicine of the present invention then, every day twice, each 1 ball, yellow wine takes.Month state of an illness of taking medicine just has improvement, and diet strengthens, and pain relief was taken medicine two months again, and the state of an illness is almost recovered, can activity freely, efficacy consolidation half a year is followed up a case by regular visits in the work that does housework followingly.
Example two, Wang Xiaoyi, man, 34 years old, Weinan, the Shaanxi Province building workman of team.
Because of before 3 years during work waist injured, not radical cure, morbidity repeatedly in recent years, lumbago reflexes to shank at ordinary times, sits the difficulty that crouches, handicapped, the state of an illness increased the weight of afterwards, can not work, once the x of hospital ray examination was diagnosed as prolapse of lumbar intervertebral disc.Come the court's treatment on July 28th, 1994, give Chinese patent medicine of the present invention at once, take medicine twice every day, each ball, the medication two weeks state of an illness greatly takes a turn for the better, and pain relief was taken medicine again one month, and the state of an illness is almost recovered, can operate as normal.
Chinese patent medicine treating both the principal and secondary aspects of a disease of the present invention, scientific strong, easy to use, toxic and side effects is little, curative effect height (effective percentage reaches 96.3%), full side's compatibility reach tonify Qi of the kidney, the effect of promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening.
Embodiment one, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is (b is Unit Weight part):
Radix Angelicae Sinensis 40b Radix Astragali 60b Radix Paeoniae Alba 35b Rhizoma Polygonati 30b
Rhizoma Chuanxiong 30b Flos Carthami 18b Olibanum 20b Myrrha 20b
Cortex Eucommiae 40b Herba Taxilli 25b Fructus Lycii 30b Radix Angelicae Pubescentis 30b
Radix Gentianae Macrophyllae 30b Radix Clematidis 30b Rhizoma Zingiberis Recens 30b
Method for making: above-mentioned 15 flavor medicines are chosen decontamination earlier, well sifted, and pulverization is made honeyed pill promptly with the first-class Mel mixing of equivalent, and every ball weighs and 9 restrains (pill quality should meet " the Chinese medicine pill prescription that Chinese pharmacopoeia is contained).
Usage, consumption: oral, every day twice, each half ball-1 ball, the normal or blood pressure person on the low side of blood pressure joins yellow wine one or two when taking medicine.
Function: tonify Qi of the kidney promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening.
Cure mainly: various arthralgia due to wind-cold-dampness disease, as rheumatism, rheumatoid arthritis, the arthralgia that prolapse of lumbar intervertebral disc, hyperosteogeny etc. causes, the muscle arteries and veins is arrested curved, numb limbs and tense tendons, it is difficult to take action, joint stuffiness etc.
Embodiment two, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is (b is Unit Weight part):
Radix Angelicae Sinensis 35b Radix Astragali 55b Radix Paeoniae Alba 30b Rhizoma Polygonati 25b
Rhizoma Chuanxiong 25b Flos Carthami 15b Olibanum 17b Myrrha 17b
Cortex Eucommiae 35b Herba Taxilli 20b Fructus Lycii 25b Radix Angelicae Pubescentis 25b
Radix Gentianae Macrophyllae 25b Radix Clematidis 25b Rhizoma Zingiberis Recens 25b
Above-mentioned Chinese medicine raw materials by weight proportion is made middle clothes Chinese patent medicine.
Embodiment three, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is (b is Unit Weight part):
Radix Angelicae Sinensis 45b Radix Astragali 65b Radix Paeoniae Alba 40b Rhizoma Polygonati 35b
Rhizoma Chuanxiong 35b Flos Carthami 21b Olibanum 23b Myrrha 23b
Cortex Eucommiae 45b Herba Taxilli 30b Fructus Lycii 35b Radix Angelicae Pubescentis 35b
Radix Gentianae Macrophyllae 35b Radix Clematidis 35b Rhizoma Zingiberis Recens 35b
Above-mentioned Chinese medicine raw materials by weight proportion is made middle clothes Chinese patent medicine.
Claims (2)
1, the Chinese patent medicine of treatment arthromyodynia is characterized in that: the raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are (b is Unit Weight part):
Radix Angelicae Sinensis 35-45b Radix Astragali 55-65b Radix Paeoniae Alba 30-40b Rhizoma Polygonati 25-35b
Rhizoma Chuanxiong 25-35b Flos Carthami 15-21b Olibanum 17-23b Myrrha 17-23b
Cortex Eucommiae 35-45b Herba Taxilli 20-30b Fructus Lycii 25-35b Radix Angelicae Pubescentis 25-35b
Radix Gentianae Macrophyllae 25-35b Radix Clematidis 25-35b Rhizoma Zingiberis Recens 25-35b
Above-mentioned Chinese medicine raw materials by weight proportion is made middle clothes Chinese patent medicine.
2, the Chinese patent medicine of treatment arthromyodynia according to claim 1 is characterized in that: the weight proportion of described raw material of Chinese medicine is (b is Unit Weight part):
Radix Angelicae Sinensis 40b Radix Astragali 60b Radix Paeoniae Alba 35b Rhizoma Polygonati 30b
Rhizoma Chuanxiong 30b Flos Carthami 18b Olibanum 20b Myrrha 20b
Cortex Eucommiae 40b Herba Taxilli 25b Fructus Lycii 30b Radix Angelicae Pubescentis 30b
Radix Gentianae Macrophyllae 30b Radix Clematidis 30b Rhizoma Zingiberis Recens 30b
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97122390 CN1053589C (en) | 1997-12-18 | 1997-12-18 | Chinese medicine Pingguxiaociwan for curing Bi-syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97122390 CN1053589C (en) | 1997-12-18 | 1997-12-18 | Chinese medicine Pingguxiaociwan for curing Bi-syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1183986A true CN1183986A (en) | 1998-06-10 |
| CN1053589C CN1053589C (en) | 2000-06-21 |
Family
ID=5176819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 97122390 Expired - Fee Related CN1053589C (en) | 1997-12-18 | 1997-12-18 | Chinese medicine Pingguxiaociwan for curing Bi-syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1053589C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028504B (en) * | 2007-03-29 | 2010-05-19 | 任开益 | Gubiping instant granules and production thereof |
| CN103893309A (en) * | 2013-11-28 | 2014-07-02 | 鹤壁职业技术学院 | Medicament for treating rheumatoid arthritis |
| CN104547633A (en) * | 2014-12-25 | 2015-04-29 | 四川天联药业有限公司 | Traditional Chinese medicine composition for treating cervical vertebra disease and preparation method thereof |
| CN104826056A (en) * | 2015-05-11 | 2015-08-12 | 宋宜德 | Traditional Chinese medicine for treating rheumatism bone pain of lower limbs |
| CN107812075A (en) * | 2017-11-24 | 2018-03-20 | 郭涤尘 | A kind of capsule for treating gout |
| CN114246899A (en) * | 2021-11-30 | 2022-03-29 | 湖南省开元博物馆 | Wind-expelling and cold-dispelling medicine for treating muscle and bone pain and preparation method thereof |
-
1997
- 1997-12-18 CN CN 97122390 patent/CN1053589C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028504B (en) * | 2007-03-29 | 2010-05-19 | 任开益 | Gubiping instant granules and production thereof |
| CN103893309A (en) * | 2013-11-28 | 2014-07-02 | 鹤壁职业技术学院 | Medicament for treating rheumatoid arthritis |
| CN103893309B (en) * | 2013-11-28 | 2015-12-09 | 鹤壁职业技术学院 | A kind of medicine for the treatment of rheumatoid arthritis |
| CN104547633A (en) * | 2014-12-25 | 2015-04-29 | 四川天联药业有限公司 | Traditional Chinese medicine composition for treating cervical vertebra disease and preparation method thereof |
| CN104547633B (en) * | 2014-12-25 | 2018-01-23 | 四川德峰药业有限公司 | A kind of Chinese medicine composition for treating cervical spondylopathy and preparation method thereof |
| CN104826056A (en) * | 2015-05-11 | 2015-08-12 | 宋宜德 | Traditional Chinese medicine for treating rheumatism bone pain of lower limbs |
| CN107812075A (en) * | 2017-11-24 | 2018-03-20 | 郭涤尘 | A kind of capsule for treating gout |
| CN114246899A (en) * | 2021-11-30 | 2022-03-29 | 湖南省开元博物馆 | Wind-expelling and cold-dispelling medicine for treating muscle and bone pain and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1053589C (en) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN1966018A (en) | Chinese medicinal formulation for treating rheumatic and rheumatoid disease | |
| CN102008655B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method thereof | |
| CN1539479A (en) | Drug for curing disease of proplapse of lumbar intervertebral disc | |
| CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1053589C (en) | Chinese medicine Pingguxiaociwan for curing Bi-syndrome | |
| CN103495126B (en) | Traditional Chinese medicine composition treating rheumatism | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN1389255A (en) | Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis | |
| CN114588242B (en) | Pharmaceutical composition for treating rheumatoid arthritis | |
| CN101912536A (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN1151814C (en) | Composite Chinese medicine for treating rheumatic Bi syndrome | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1181878C (en) | Detumescence plaster | |
| CN1062172C (en) | Medicine for treating cervical spondylopathy | |
| CN1364608A (en) | Powder for curing gout | |
| CN1309406C (en) | Medicinal preparation for treating rheumatism and rheumatoid diseases | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1119161C (en) | Medicine for treating rheumatisms | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN101623460B (en) | Medicine for treating rheumatic pain and preparation method thereof | |
| CN1772230A (en) | Medicine Yangrongtongbining | |
| CN1262110A (en) | Medicine for treating pain of lumbus, leg, neck and shoulder | |
| CN1616044A (en) | Chinese medicine composition for treating chronic hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |